ModernaTX granted patent for lipid nanoparticle delivery to airway epithelium.
The filing
On November 10, 2026, the USPTO granted US Patent 12,788,726 to ModernaTX for processes to prepare lipid nanoparticle compositions that deliver therapeutic or prophylactic agents to airway epithelium. The patent covers methods for formulating these nanoparticles to target the airway lining, as outlined in the granted document PROCESSES FOR PREPARING LIPID NANOPARTICLE COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUM (opens in a new tab).
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.